SIRS Lab Ditches In-House Gene-Expression Platform for Illumina System | GenomeWeb
NEW YORK (GenomeWeb News) — SIRS-Lab has adopted an Illumina gene-expression system for its expression services, and has stopped using the internally developed gene-expression system it had offered over the past five years, according to a company scientist.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.